+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biosafety Testing Service Market - Global Forecast 2026-2032- Product Image
Biosafety Testing Service Market - Global Forecast 2026-2032- Product Image
Sale

Biosafety Testing Service Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6280654
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biosafety Testing Services: Executive Summary

Biosafety testing services support the evaluation of biological materials, medicines, vaccines, cell and gene therapies, and manufacturing inputs for contamination, identity, purity, potency, and other safety-related attributes. Demand is shaped by regulatory expectations, increasingly complex biologic modalities, supply-chain controls, and the need for reliable evidence across development and production stages. Service providers must therefore combine validated analytical methods, quality systems, technical specialization, and strong documentation practices.

Regulatory Complexity and Advanced Biologics Are Reshaping Testing

The biosafety testing landscape is being transformed by the growth of complex biologics, viral vectors, cell-based products, and novel manufacturing platforms. These products can introduce difficult-to-characterize risks, increasing the importance of fit-for-purpose assay design, method validation, sample integrity, and comparability testing. Regulators and sponsors are also placing greater emphasis on data integrity, traceability, contamination control, and lifecycle management. As a result, testing programs are moving toward integrated, risk-based workflows rather than isolated assays performed late in development.

Artificial Intelligence Is Strengthening Analytical Workflows and Quality Oversight

Artificial intelligence can improve biosafety testing by supporting image interpretation, anomaly detection, trend analysis, assay optimization, and review of large analytical datasets. Machine-learning tools may help identify recurring contamination signals or prioritize samples for investigation, while natural-language systems can assist with document classification and protocol review. However, AI-generated outputs require qualified human oversight, representative training data, documented validation, cybersecurity controls, and clear accountability. Adoption is most credible where AI augments validated laboratory processes instead of replacing scientific judgment or regulated quality review.

Regional Insights: Regulation, Manufacturing Depth, and Access Shape Adoption

North America benefits from established biopharmaceutical development and sophisticated regulatory infrastructure, supporting demand for specialized and high-throughput testing. Europe combines mature quality systems with coordinated regulatory expectations across the European Union, while individual markets in the region continue to maintain distinct operational requirements. Asia-Pacific is supported by expanding biomanufacturing capabilities and growing demand for locally accessible testing, particularly across Australia, China, India, Japan, and South Korea. Latin America, including Brazil and Mexico, is developing testing capacity alongside broader pharmaceutical and vaccine activity. The Middle East is emphasizing healthcare resilience and advanced life-science capabilities, with the GCC serving as an important coordination context. Africa remains diverse, with opportunities linked to laboratory strengthening, public-health programs, local production, and improved access to accredited testing.

Group Insights: Trade, Security, and Regulatory Alignment Influence Service Models

ASEAN markets are encouraging regional manufacturing and laboratory development, although regulatory implementation and technical capacity remain uneven. BRICS economies encompass substantial scientific and manufacturing capabilities but differ in regulatory systems, infrastructure, and cross-border data practices. The European Union supports harmonized pharmaceutical oversight while retaining national operational considerations. G7 members generally combine advanced research ecosystems, mature quality frameworks, and high expectations for validated evidence. GCC countries are investing in healthcare and industrial diversification, creating demand for dependable biosafety capabilities. NATO members also reflect the importance of resilient medical supply chains, preparedness, and secure laboratory infrastructure, although participation in the alliance does not create a single biosafety-testing regime.

Country Insights: National Capabilities and Regulatory Context Create Different Priorities

The United States and Canada have deep biopharmaceutical ecosystems and strong demand for comprehensive, documented testing programs. Germany, France, Italy, Spain, and the United Kingdom operate within highly developed European life-science environments, with attention to regulatory conformity, quality systems, and specialized biologic characterization. China, India, Japan, and South Korea are strengthening domestic research, manufacturing, and laboratory capabilities, while sponsors increasingly seek testing continuity across development and commercial production. Australia combines advanced research capacity with geographically dispersed supply considerations. Brazil and Mexico are important Latin American markets where regulatory alignment, local laboratory access, and supply-chain reliability remain central priorities. Russia has established scientific and pharmaceutical capabilities, but organizations operating there must account for applicable regulatory, trade, and data-governance conditions.

Action Priorities for Biosafety Testing Service Leaders

Industry leaders should build modular testing portfolios that address conventional biologics as well as cell, gene, and viral-vector products. They should invest in validated automation, secure data systems, method-transfer capabilities, and documented AI governance rather than pursuing technology adoption without quality controls. Regional laboratory networks and qualified partner arrangements can improve continuity when samples, specialized equipment, or expert personnel are constrained. Leaders should also maintain early regulatory engagement, harmonize standard operating procedures across sites, and offer transparent evidence packages that support audits and submissions. Finally, workforce development in assay science, bioinformatics, quality assurance, and biosafety should be treated as a strategic capability.

Research Methodology: Structured Synthesis of Market Drivers and Operating Conditions

This executive summary uses a qualitative, evidence-oriented framework for assessing biosafety testing services. The analysis considers regulatory expectations, biologic-product complexity, laboratory capabilities, manufacturing trends, data and quality requirements, artificial-intelligence applications, and regional operating conditions. Regional, group, and country discussions are integrated to distinguish common structural drivers from national differences. No market estimates, shares, forecasts, or company-specific claims are used; conclusions are limited to broadly verifiable industry dynamics and operational implications.

Conclusion: Reliable, Integrated Testing Is Becoming a Strategic Requirement

Biosafety testing services are evolving from a compliance activity into a strategic component of biologic development, manufacturing control, and supply-chain resilience. The strongest operating models will connect specialized assays, validated technology, robust quality systems, and regulatory intelligence across jurisdictions. Artificial intelligence can add value when governed as part of a controlled analytical environment. Organizations that improve scientific depth, data integrity, regional continuity, and workforce capability will be better positioned to support increasingly complex biological products safely and consistently.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biosafety Testing Service Market, by Service Type
7.1. Introduction
7.2. Bioburden Testing
7.3. Cell And Gene Therapy Specific Testing
7.4. Endotoxin Testing
7.5. Environmental Monitoring
7.5.1. Air Monitoring
7.5.2. Surface Monitoring
7.5.3. Water Monitoring
7.6. Immunoassay Testing
7.7. Microbiological Testing
7.8. Molecular Testing
7.8.1. Digital PCR
7.8.2. Next Generation Sequencing
7.8.3. Polymerase Chain Reaction
7.8.4. Quantitative PCR
7.9. Mycoplasma Testing
7.10. Residuals And Impurity Testing
7.11. Stability Testing
7.12. Sterility Testing
7.13. Viral Clearance Testing
8. Biosafety Testing Service Market, by Sample Type
8.1. Introduction
8.2. Biologics And Vaccines
8.3. Cell Therapy Products
8.4. Clinical Samples
8.5. Drug Products
8.6. Environmental Swabs And Surfaces
8.7. Food Samples
8.8. Medical Devices
8.9. Raw Materials
8.10. Water And Air Samples
9. Biosafety Testing Service Market, by Technology Platform
9.1. Introduction
9.2. Automated High Throughput Systems
9.3. Chromatography And Mass Spectrometry
9.4. Culture Based Methods
9.5. Immunoassays
9.5.1. Enzyme Linked Immunosorbent Assay
9.5.2. Lateral Flow And Rapid Tests
9.6. Next Generation Sequencing Platforms
9.7. Rapid Point Of Care Technologies
10. Biosafety Testing Service Market, by End User
10.1. Introduction
10.2. Academic And Research Institutions
10.3. Biotechnology Companies
10.4. Contract Research Organizations
10.5. Cosmetics Companies
10.6. Environmental Agencies
10.7. Food And Beverage Companies
10.8. Hospitals And Clinical Laboratories
10.9. Medical Device Manufacturers
10.10. Pharmaceutical Manufacturers
10.11. Veterinary Laboratories
11. Biosafety Testing Service Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Biosafety Testing Service Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Biosafety Testing Service Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Avance Biosciences, LLC
15.2. bioMérieux SA
15.3. BioReliance Corporation
15.4. Charles River Laboratories International, Inc.
15.5. Eurofins Scientific SE
15.6. Intertek Group plc
15.7. Laboratory Corporation of America Holdings
15.8. Microbac Laboratories, Inc.
15.9. Nelson Laboratories, LLC
15.10. Pace Analytical Services LLC
15.11. Sartorius AG
15.12. SGS Société Générale de Surveillance SA
15.13. Sterigenics U.S., LLC
15.14. Thermo Fisher Scientific Inc.
15.15. Toxikon Corporation
15.16. WuXi AppTec Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Biosafety Testing Service Market, Years Considered for the Study
FIGURE 2. Global Biosafety Testing Service Market, Research Design
FIGURE 3. Global Biosafety Testing Service Market, Research Framework
FIGURE 4. Global Biosafety Testing Service Market, Data Triangulation
FIGURE 5. Global Biosafety Testing Service Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Biosafety Testing Service Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global Biosafety Testing Service Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Biosafety Testing Service Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 9. Global Biosafety Testing Service Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Biosafety Testing Service Market Size, by Technology Platform, 2025 vs 2032 (%)
FIGURE 11. Global Biosafety Testing Service Market Size, by Technology Platform, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Biosafety Testing Service Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Biosafety Testing Service Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Biosafety Testing Service Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Biosafety Testing Service Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Biosafety Testing Service Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Biosafety Testing Service Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Biosafety Testing Service Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Biosafety Testing Service Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Biosafety Testing Service Market Segmentation & Coverage
TABLE 2. Global Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 3. Global Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Bioburden Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Bioburden Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Bioburden Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cell And Gene Therapy Specific Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cell And Gene Therapy Specific Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cell And Gene Therapy Specific Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Endotoxin Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Endotoxin Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Endotoxin Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Environmental Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Environmental Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Environmental Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Air Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Air Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Air Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Surface Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Surface Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Surface Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Water Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Water Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Water Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Immunoassay Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Immunoassay Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Immunoassay Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Microbiological Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Microbiological Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Microbiological Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Molecular Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Molecular Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Molecular Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Quantitative PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Quantitative PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Quantitative PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Mycoplasma Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Mycoplasma Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Mycoplasma Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Residuals And Impurity Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Residuals And Impurity Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Residuals And Impurity Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Stability Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Stability Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Stability Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Sterility Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Sterility Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Sterility Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Viral Clearance Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Viral Clearance Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Viral Clearance Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 62. Global Biologics And Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Biologics And Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Biologics And Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Cell Therapy Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Cell Therapy Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Cell Therapy Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Clinical Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Clinical Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Clinical Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Drug Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Drug Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Drug Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Environmental Swabs And Surfaces Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Environmental Swabs And Surfaces Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Environmental Swabs And Surfaces Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Food Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Food Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Food Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Medical Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Medical Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Medical Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Raw Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Raw Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Raw Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Water And Air Samples Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Water And Air Samples Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Water And Air Samples Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 90. Global Automated High Throughput Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Automated High Throughput Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Automated High Throughput Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Chromatography And Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Chromatography And Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Chromatography And Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Culture Based Methods Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Culture Based Methods Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Culture Based Methods Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Enzyme Linked Immunosorbent Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Enzyme Linked Immunosorbent Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Enzyme Linked Immunosorbent Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Lateral Flow And Rapid Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Lateral Flow And Rapid Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Lateral Flow And Rapid Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Next Generation Sequencing Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Next Generation Sequencing Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Next Generation Sequencing Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Rapid Point Of Care Technologies Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Rapid Point Of Care Technologies Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Rapid Point Of Care Technologies Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Global Academic And Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Academic And Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Academic And Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Cosmetics Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Cosmetics Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Cosmetics Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Environmental Agencies Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Environmental Agencies Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Environmental Agencies Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Food And Beverage Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Food And Beverage Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Food And Beverage Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Hospitals And Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Hospitals And Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Hospitals And Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Medical Device Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Medical Device Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Medical Device Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Pharmaceutical Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Pharmaceutical Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Pharmaceutical Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Veterinary Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Veterinary Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Veterinary Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Biosafety Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Biosafety Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. North America Biosafety Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. North America Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 156. North America Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 157. North America Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 158. North America Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 159. North America Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 160. North America Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 161. North America Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Latin America Biosafety Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Latin America Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 164. Latin America Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 165. Latin America Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 166. Latin America Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 167. Latin America Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 168. Latin America Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 169. Latin America Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Europe Biosafety Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Europe Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 172. Europe Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 173. Europe Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 174. Europe Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 175. Europe Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 176. Europe Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 177. Europe Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Middle East Biosafety Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Middle East Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 180. Middle East Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 181. Middle East Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 182. Middle East Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 183. Middle East Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 184. Middle East Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 185. Middle East Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Africa Biosafety Testing Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Africa Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 188. Africa Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 189. Africa Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 190. Africa Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 191. Africa Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 192. Africa Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 193. Africa Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Global Biosafety Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. ASEAN Biosafety Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. ASEAN Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 197. ASEAN Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 198. ASEAN Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 199. ASEAN Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 200. ASEAN Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 201. ASEAN Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 202. ASEAN Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. GCC Biosafety Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. GCC Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 205. GCC Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 206. GCC Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 207. GCC Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 208. GCC Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 209. GCC Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 210. GCC Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. European Union Biosafety Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 212. European Union Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 213. European Union Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 214. European Union Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 215. European Union Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 216. European Union Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 217. European Union Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 218. European Union Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 219. BRICS Biosafety Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. BRICS Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 221. BRICS Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 222. BRICS Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 223. BRICS Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 224. BRICS Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 225. BRICS Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 226. BRICS Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. G7 Biosafety Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 228. G7 Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 229. G7 Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 230. G7 Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 231. G7 Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 232. G7 Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 233. G7 Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 234. G7 Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. NATO Biosafety Testing Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 236. NATO Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 237. NATO Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 238. NATO Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 239. NATO Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 240. NATO Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 241. NATO Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 242. NATO Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Global Biosafety Testing Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 244. United States Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 245. United States Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 246. United States Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 247. United States Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 248. United States Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 249. United States Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 250. United States Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 251. United States Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Canada Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 253. Canada Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 254. Canada Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 255. Canada Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 256. Canada Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 257. Canada Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 258. Canada Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 259. Canada Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Mexico Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 261. Mexico Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 262. Mexico Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 263. Mexico Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 264. Mexico Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 265. Mexico Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 266. Mexico Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 267. Mexico Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Brazil Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 269. Brazil Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 270. Brazil Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 271. Brazil Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 272. Brazil Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 273. Brazil Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 274. Brazil Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 275. Brazil Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. United Kingdom Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 277. United Kingdom Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 278. United Kingdom Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 279. United Kingdom Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 280. United Kingdom Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 281. United Kingdom Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 282. United Kingdom Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 283. United Kingdom Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. Germany Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 285. Germany Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 286. Germany Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 287. Germany Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 288. Germany Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 289. Germany Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 290. Germany Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 291. Germany Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. France Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 293. France Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 294. France Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 295. France Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 296. France Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 297. France Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 298. France Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 299. France Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 300. Russia Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 301. Russia Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 302. Russia Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 303. Russia Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 304. Russia Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 305. Russia Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 306. Russia Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 307. Russia Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Italy Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 309. Italy Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 310. Italy Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 311. Italy Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 312. Italy Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 313. Italy Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 314. Italy Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 315. Italy Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. Spain Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 317. Spain Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 318. Spain Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 319. Spain Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 320. Spain Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 321. Spain Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 322. Spain Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 323. Spain Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 324. China Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 325. China Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 326. China Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 327. China Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 328. China Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 329. China Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 330. China Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 331. China Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 332. India Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 333. India Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 334. India Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 335. India Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Million)
TABLE 336. India Biosafety Testing Service Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 337. India Biosafety Testing Service Market Size, by Technology Platform, 2017-2032 (USD Million)
TABLE 338. India Biosafety Testing Service Market Size, by Immunoassays, 2017-2032 (USD Million)
TABLE 339. India Biosafety Testing Service Market Size, by End User, 2017-2032 (USD Million)
TABLE 340. Japan Biosafety Testing Service Market Size, 2017-2032 (USD Million)
TABLE 341. Japan Biosafety Testing Service Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 342. Japan Biosafety Testing Service Market Size, by Environmental Monitoring, 2017-2032 (USD Million)
TABLE 343. Japan Biosafety Testing Service Market Size, by Molecular Testing, 2017-2032 (USD Mill

Companies Mentioned

  • Avance Biosciences, LLC
  • bioMérieux SA
  • BioReliance Corporation
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • Intertek Group plc
  • Laboratory Corporation of America Holdings
  • Microbac Laboratories, Inc.
  • Nelson Laboratories, LLC
  • Pace Analytical Services LLC
  • Sartorius AG
  • SGS Société Générale de Surveillance SA
  • Sterigenics U.S., LLC
  • Thermo Fisher Scientific Inc.
  • Toxikon Corporation
  • WuXi AppTec Co., Ltd.

Related Reports

CMC Biosafety Testing Market - Global Forecast 2026-2032 - Product Image

CMC Biosafety Testing Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Virology Specimen Collection Market - Global Forecast 2026-2032 - Product Image

Virology Specimen Collection Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Containment Ventilated Enclosures Market - Global Forecast 2026-2032 - Product Image

Containment Ventilated Enclosures Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Animal Workstations Market - Global Forecast 2026-2032 - Product Image

Animal Workstations Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Biosafety Consulting Services Market - Global Forecast 2026-2032 - Product Image

Biosafety Consulting Services Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.